JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 27, 2018

Media advisory: To contact corresponding author Michael L. Barnett, M.D., M.S., email Chris Sweeney at csweeney@hsph.harvard.edu. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.12354

Bottom Line: Laws passed in 32 states promote the use of telemedicine by mandating coverage and reimbursement. Telemedicine is the remote evaluation, diagnosis and treatment of patients using electronic communication. In this study, claims data from a large, private U.S. health plan were analyzed to estimate the growth in telemedicine from 2005 to 2017. Researchers report telemedicine use increased substantially during those years but was still uncommon by 2017. Annual telemedicine visits among all members in this health plan increased from 0.020 to 6.57 per 1,000 members between 2005-2017, with the largest increases in use beginning in 2015. Most telemedicine users lived in urban areas, although the attention given to telemedicine is often to encourage its use in rural settings. These data are from a single insurer whose population and policies may not be generalized to other populations.

Authors: Michael L. Barnett, M.D., M.S., Harvard T. H. Chan School of Public Health, Boston, and coauthors

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.12354)

Editor’s Note:  The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 27, 2018

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 202-572-2044. The full report is available on the For The Media website.

Want to embed a link to this report in your story? Link will be live at the embargo time and all links to all USPSTF articles remain free indefinitely: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.17772

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) finds limited or inconsistent evidence on the benefits of primary care interventions to prevent child maltreatment (defined as abuse, neglect or both). Children with signs or symptoms suggesting maltreatment should be assessed or reported according to applicable state laws.

Background: The USPSTF routinely makes recommendations about the effectiveness of preventive care services. This latest statement reaffirms its 2013 position that there is insufficient evidence on the benefits of primary care interventions to prevent child maltreatment. In 2016, approximately 676,000 children in the United States experienced maltreatment and more than 1,700 children died as a result.

The USPSTF Recommendation:

Related Material

The following related elements from The JAMA Network are also available on the For The Media website:

— An interview with Alex R. Kemper, M.D., M.P.H., M.S., USPSTF member and coauthor of the recommendation statement. The transcript is available here.

— Interventions to Prevent Child Maltreatment – U.S. Preventive Services Task Force Recommendation Statement

— Primary Care Interventions to Prevent Child Maltreatment – Updated Evidence Report and Systematic Review for the U.S. Preventive Services Task Force

— JAMA editorial: Preventing Maltreatment of Children

— JAMA Patient Page: Interventions to Prevent Child Maltreatment

(doi:10.1001/jama.2018.17772)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 20, 2018

Media advisory: To contact corresponding author Emily N. Ussery, Ph.D., email CDC Media Relations at media@cdc.gov. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.17797

Bottom Line: Sitting too long and being physically inactive can be bad for your health, and it’s important to understand how common these behaviors are among U.S. adults. This study used data from a nationally representative survey of about 5,900 adults to examine sitting time and leisure-time physical activity. Researchers report 1 in 4 adults sit for more than 8 hours a day, 4 in 10 are physically inactive with no moderate or vigorous activity during the week, and 1 in 10 reported both sitting more than 8 hours a day and being physically inactive. Limitations of the study include self-reported data. Practitioners can help support programs and policies that help adults sit less and move more.

Authors: Emily N. Ussery, Ph.D., Centers for Disease Control and Prevention, Atlanta, and coauthors

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.17797)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

A summary video is available for the study, “Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults,” by Cara Tannenbaum, M.D., M.Sc., Université de Montréal, Quebec, Canada, and coauthors. The video can be viewed on this page and embedded on your website by copying and pasting the HTML code below. To download the video, email mediarelations@jamanetwork.org for information.

Video embed code:

<div style="display: block; position: relative; max-width: 300px;"><div style="padding-top: 50%;"><iframe src="//players.brightcove.net/864352215001/default_default/index.html?videoId=5858459784001" allowfullscreen webkitallowfullscreen mozallowfullscreen style="width: 100%; height: 100%; position: absolute; top: 0px; bottom: 0px; right: 0px; left: 0px;"></iframe></div></div>

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 13, 2018

Media advisory: To contact corresponding author Talia Puzantian, Pharm.D., BCPP, email Ivan Alber at ialber@kgi.edu. To contact corresponding author Kirk E. Evoy, Pharm.D., BCACP, BC-ADM, CTTS, email Nick Nobel at nobel@utexas.edu. The full studies are available on the For The Media website.

Want to embed a link to these studies in your story? Links will be live at the embargo time

Puzantian study: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.12291

Evoy study: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.15892

Bottom Line: Two studies looked at the availability of naloxone, an antidote for opioid overdoses, from pharmacies in two states that have passed legislation to allow pharmacists to dispense the medication without a physician’s prescription.

What: Having access to naloxone can reduce the risk of death from an opioid overdose. Legislation in California has allowed trained pharmacists to provide naloxone without a physician’s prescription since 2016. In this study, an anonymous telephone survey of some California community pharmacies was conducted in 2018 with interviewers posing as potential customers who asked pharmacy staff if they could get naloxone without a prescription. Less than 25 percent of about 1,150 retail pharmacies said they were giving naloxone to patients without a physician prescription. Of the pharmacies providing the medication, only about 50 percent had nasal naloxone in stock. Limitations of the study include a lack of data on the reasons why pharmacies weren’t providing the naloxone.

Authors: Talia Puzantian, Pharm.D., BCPP, Keck Graduate Institute School of Pharmacy and Health Sciences, Claremont, California, and James J. Gasper, Pharm.D., BCPP, University of California, San Francisco

(doi:10.1001/jama.2018.12291)

What: A second study evaluated naloxone accessibility from chain pharmacies in Texas under a standing order from prescribers almost three years after Texas enacted legislation. Under a standing order, prescribers may authorize pharmacists to dispense naloxone without a prescription. In this study, interviewers posed as customers and spoke to pharmacists about wanting to purchase naloxone to have on hand in the event they had to respond to an opioid overdose. Among about 2,300 pharmacies, 84 percent indicated they would dispense the naloxone and 69 percent of pharmacies had the medication in stock. The study was limited by interviewing only one pharmacist per pharmacy and including only Texas chain pharmacies.

Authors: Kirk E. Evoy, Pharm.D., BCACP, BC-ADM, CTTS, the University of Texas at Austin, and coauthors

(doi:10.1001/jama.2018.15892)

Related Material: The editorial, “Overcoming Inertia to Improve Medication Use and Deprescribing,” by Michael A. Steinman, M.D., University of California San Francisco, California, and C. Seth Landefeld, M.D., University of Alabama at Birmingham, is available on the For The Media website.

To Learn More: The full studies are available on the For The Media website.

Editor’s Note:  Please see the articles for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 8 A.M. (ET), MONDAY, NOVEMBER 12, 2018

Media advisory: To contact co-author Katrina L. Piercy, Ph.D., R.D., email Frances Bevington at Frances.Bevington@hhs.gov. The article is available on the For The Media website.

Want to embed a link to this report in your story? Link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14854

Bottom Line: Updated physical activity guidelines released by the U.S. Department of Health and Human Services (HHS) tell Americans to get moving, and for how long, with aerobic and muscle-strengthening activities.

Background: Most adults and adolescents in the United States aren’t active enough, although being physically active is one of the most important things people can do to improve their health and reduce their risk for many chronic diseases and conditions.

Who and When:  These updated Physical Activity Guidelines for Americans are based on a review of the current science on physical activity and health.

Key Recommendations:

Conclusions: Health professionals and policymakers should promote awareness of the updated guidelines and support efforts to implement programs, practices and policies to facilitate increased physical activity to improve the health of the U.S. population.

Authors: Katrina L. Piercy, Ph.D., R.D., U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Rockville, Maryland, and coauthors

Related Material

The following related elements from The JAMA Network are also available on the For The Media website:

— A summary video is available to view on this page and to embed on your website by copying and pasting the HTML code below. To download the video, email mediarelations@jamanetwork.org for information.

— The JAMA editorial, “New Physical Activity Guidelines – A Call to Activity for Clinicians and Patients,” by Paul D. Thompson, M.D., Hartford Hospital, Hartford, Connecticut, and Thijs M. H. Eijsvogels, Ph.D., Radboud University Medical Center, Nijmegen, the Netherlands.

— The JAMA Viewpoint, “Physical Activity Guidelines for Health and Prosperity in the United States,” by Brett P. Giroir, M.D., and Don Wright, M.D., M.P.H., U.S. Department of Health and Human Services.

Editor’s Note: These guidelines will be presented at the American Heart Association Scientific Sessions 2018 on Monday, November 12.

Editor’s Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Video embed code:

<div style="display: block; position: relative; max-width: 300px;"><div style="padding-top: 50%;"><iframe src="//players.brightcove.net/864352215001/default_default/index.html?videoId=5853923900001" allowfullscreen webkitallowfullscreen mozallowfullscreen style="width: 100%; height: 100%; position: absolute; top: 0px; bottom: 0px; right: 0px; left: 0px;"></iframe></div></div>

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 13, 2018

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 202-572-2044. The full report is available on the For The Media website.

Want to embed a link to this report in your story? Link will be live at the embargo time and all links to all USPSTF articles remain free indefinitely: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.16789

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends screening adults 18 and older, including pregnant women, for unhealthy alcohol use in primary care settings. Those patients who engage in risky or hazardous drinking should be offered brief behavioral counseling interventions to reduce unhealthy alcohol use. The USPSTF also concludes the evidence is insufficient regarding screening for alcohol use in adolescents 12 to 17 in primary care settings.

Background: The USPSTF routinely makes recommendations about the effectiveness of preventive care services. This latest statement is an update of its 2013 recommendation on screening for unhealthy alcohol use in primary care settings. Excessive alcohol use is one of the most common causes of premature death in the United States, with an estimated 88,000 deaths attributed to alcohol occurring annually in the United States from 2006 to 2010. Alcohol use during pregnancy is also one of the major preventable causes of birth defects and developmental disabilities.

The USPSTF Concludes:

Related Material

The following related elements from The JAMA Network are also available on the For The Media website:

— An interview with Susan J. Curry, Ph.D., co-author of the recommendation statement.

— Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults – U.S. Preventive Services Task Force Recommendation Statement

— Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults – Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

— JAMA editorial: Screening for Unhealthy Alcohol Use

— JAMA Internal Medicine editorial: Unhealthy Alcohol Use in Primary Care – The Elephant in the Examination Room

— JAMA Psychiatry editorial: Screening and Brief Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adults 18 Years and Older, Including Pregnant Women

— JAMA Pediatrics editorial: Alcohol Use Screening and Behavioral Counseling With Adolescents in Primary Care

— JAMA Patient Page: Screening and Counseling to Reduce Unhealthy Alcohol Use

To Learn More: The full report is available on the For The Media website.

(doi:10.1001/jama.2018.16789)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 6, 2018

Media advisory: To contact corresponding author Yuichiro Yano, M.D., Ph.D., email Sarah Avery at sarah.avery@duke.edu. To contact corresponding author Sang Min Park, M.D., Ph.D., M.P.H., email smpark.snuh@gmail.com. The full studies are available on the For The Media website.

Want to embed a link to these studies in your story? Links will be live at the embargo time

Yano study: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.13551

Park study: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.16501

Bottom Line: Two studies and two editorials examine the relationship between having high blood pressure as an adult younger than 40 and increased risk of later cardiovascular disease events.

What: In one study, about 4,800 African American and white adults had blood pressure measurements taken before age 40. Adults with elevated blood pressure (systolic blood pressure [SBP] of 120 to 129 mm Hg; diastolic blood pressure [DBP] less than 80 mm Hg),  stage 1 hypertension (SBP of 130 to 139 mm Hg; DBP of 80 to 89 mm Hg) or stage 2 hypertension (SBP of 140 mm Hg or greater; DBP of 90 mm Hg or greater) before age 40 had an associated higher risk for cardiovascular disease (CVD) events such as fatal and nonfatal coronary heart disease, heart failure or stroke compared with adults who had normal blood pressure during a follow-up of about 19 years. The blood pressure classification in the new guidelines from the American College of Cardiology/American Heart Association may help identify young adults at higher risk for cardiovascular disease events.

Authors: Yuichiro Yano, M.D., Ph.D., Duke University, Durham, North Carolina, and coauthors

(doi:10.1001/jama.2018.13551)

What: A second study included data from the Korean National Health Insurance Service for about 2.5 million adults between the ages of 20 and 39 who had a blood pressure measurements taken over four years and who were followed up over another 10 years for CVD (defined as two or more days of hospitalization due to CVD or death due to CVD). Researchers report that adults with stage 1 or 2 hypertension before age 40 had an increased risk of subsequent CVD compared with adults with normal blood pressure. The study population was from a single country so the results may not be generalizable to others.

Authors: Sang Min Park, M.D., Ph.D., M.P.H., Seoul National University, Seoul, South Korea, and coauthors

(doi:10.1001/jama.2018.16501)

Related Material: The editorials, “High Blood Pressure in Young Adulthood and Risk of Premature Cardiovascular Disease,” by Ramachandran S. Vasan, M.D., Boston University School of Medicine, Boston, and “Hypertension—A Public Health Challenge of Global Proportions,” by Naomi D. L. Fisher, M.D., Brigham and Women’s Hospital, Boston, and Gregory Curfman, M.D., Deputy Editor, JAMA, also are available on the For The Media website.

To Learn More: The full studies are available on the For The Media website.

Editor’s Note:  Please see the articles for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Within the last 2 years, major guidelines have been issued from U.S.-based and European organizations that differ in their recommendations for the diagnosis and treatment of hypertension. In this podcast, experts from both sides of the Atlantic—Paul Whelton, M.D., from the United States (Tulane University, New Orleans, Louisiana) and Bryan Williams, M.D., from Europe (University College London in England)—discuss the similarities and differences in these guidelines and the basis for the differences. They were interviewed by JAMA editors Greg Curfman, M.D., and Ed Livingston, M.D.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 6, 2018

Media advisory: To contact corresponding author Barry A. Borlaug, M.D., email Traci Klein at newsbureau@mayo.edu. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14852

Bottom Line: About half of patients with heart failure have a form of the condition with normal pump function that is called heart failure with preserved ejection fraction. This form of heart failure is characterized by symptoms such as fatigue, shortness of breath and difficulty being physically active. This randomized clinical trial of 105 patients with this kind of heart failure examined the effects on exercise capacity after four weeks of inhaled, nebulized inorganic nitrite compared with placebo. Researchers report the treatment wasn’t effective compared with placebo for improving exercise capacity in patients.

Authors: Barry A. Borlaug, M.D., Mayo Clinic and Foundation, Rochester, Minnesota, and coauthors

Visual Abstract: This is the link to the abstract when the embargo lifts.

Related Material: The editorial, “Hypertension—A Public Health Challenge of Global Proportions,” by Naomi D. L. Fisher, M.D., Brigham and Women’s Hospital, Boston, and Gregory Curfman, M.D., Deputy Editor, JAMA, is available on the For The Media website.

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.14852)

Editor’s Note:  Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 23, 2018

Media advisory: To contact corresponding author Ford Vox, M.D., email Kerry Ludlam at kerry.ludlam@shepherd.org. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.10264

Bottom Line: Medical crowdfunding is using social media to appeal for help in paying for medical care. These campaigns can fill insurance gaps but they can also raise money for scientifically unsupported, ineffective or potentially dangerous treatments. This study examined crowdfunding activity for five such treatments since November 2015 and identified more than 1,000 campaigns that raised nearly $6.8 million. The campaigns collected money for homeopathic or naturopathic cancer treatments, hyperbaric oxygen therapy for brain injury, stem cell therapies for brain and spinal cord injury, and long-term antibiotic therapy for chronic Lyme Disease. Limitations of the study include only five treatments and four crowdfunding platforms were analyzed.

Authors: Ford Vox, M.D., Brain Injury Rehabilitation, Shepherd Center, Atlanta, and coauthors

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.10264)

Editor’s Note:  Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 23, 2018

Media advisory: To contact corresponding author Ipek Gurol-Urganci, Ph.D., email press@lshtm.ac.uk. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14997

Bottom Line: Treatment for women with stress urinary incontinence (SUI) can include inserting a mesh sling to support the urethra. An estimated 250,000 midurethral mesh sling (MUS) operations were performed in 2010 in the United States. There is concern that some women experience pain, persistent urinary incontinence and other issues but little clinical trial evidence exists about these longer-term outcomes. This observational study examined long-term mesh removal and reoperations in about 95,000 women in England who underwent MUS operations for SUI between 2006 and 2015. Within nine years, the rate of sling removal was 3.3 percent and the rate of reoperation for SUI was 4.5 percent. Reasons for removal or reoperations weren’t available.

Authors: Ipek Gurol-Urganci, Ph.D., London School of Hygiene & Tropical Medicine, London, and coauthors

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.14997)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 23, 2018

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 202-572-2044. The full report is available on the For The Media website.

Want to embed a link to this report in your story? Link will be live at the embargo time and all links to all USPSTF articles remain free indefinitely: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14741

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends clinicians screen women of reproductive age for intimate partner violence and then connect women who screen positive to ongoing support services. However, current evidence is insufficient regarding screening older or vulnerable adults for abuse and neglect.

Background: The USPSTF routinely makes recommendations about the effectiveness of preventive care services. This latest statement is an update of its 2013 recommendation on screening for intimate partner violence (IPV), elder abuse, and abuse of vulnerable adults, which are common in the United States but often remain undetected. In addition to the immediate effects of intimate partner violence, which may include injury and death, there may be other health consequences, including the development of depression, anxiety, substance abuse, and chronic pain. Long-term negative health effects from elder abuse may include higher risk of nursing home placement and death.

The USPSTF Concludes:

Related Material

The following related elements from The JAMA Network are also available on the For The Media website:

— Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults – US Preventive Services Task Force Final Recommendation Statement

— Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults – Evidence Report and Systematic Review for the US Preventive Services Task Force

— JAMA editorial: Challenges and Opportunities for Studying Routine Screening for Abuse

— JAMA Internal Medicine editorial: Addressing Intimate Partner Violence and Abuse of Older or Vulnerable Adults in the Health Care Setting – Beyond Screening

— JAMA Patient Page: Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults

To Learn More: The full report is available on the For The Media website.

(doi:10.1001/jama.2018.14741)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Listen to an interview with Philip S. Wells, M.D., of the University of Ottawa, Canada, co-author of the JAMA study, “Venous Thromboembolism – Advances in Diagnosis and Treatment.” The podcast is available for listening and download on this page.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 16, 2018

Media advisory: To contact corresponding author Brett Burstein, M.D.C.M., Ph.D., M.P.H., email Stephanie Tsirgiotis at stephanie.tsirgiotis@muhc.mcgill.ca. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.9245

Bottom Line: Revised guidelines recommend against routine X-rays for infants with bronchiolitis, a viral lower respiratory tract infection that often lands babies in the hospital. Unnecessary X-rays contribute to health care costs and radiation exposure. Despite the guidelines, an analysis of emergency department visits in the United States suggests no decrease in the rate of X-rays from 2007 to 2015, with nearly half of children under 2 with bronchiolitis still getting imaging. The study lacked clinical data to determine the appropriateness of X-rays.

Authors: Brett Burstein, M.D.C.M., Ph.D., M.P.H., Montreal Children’s Hospital, Montreal, Canada, and coauthors

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.9245)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 16, 2018

Media advisory: To contact corresponding author David Arterburn, M.D., M.P.H., email Rebecca Hughes (Rebecca.F.Hughes@kp.org) or Heather Platisha (Heather.Platisha@creation.io). The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14619

Bottom Line: Macrovascular disease events, which include heart attack and stroke, are a leading cause of illness and death for patients with type 2 diabetes. Medical management, including lifestyle changes, may not reduce patient risk but bariatric surgery may help. In this observational study of about 20,000 patients with severe obesity and type 2 diabetes who underwent bariatric surgery or received usual medical care for diabetes, bariatric surgery was associated with a lower risk of macrovascular disease events at five years of follow-up (2.1 percent vs 4.3 percent). The findings require confirmation in randomized clinical trials.

Authors: David Arterburn, M.D., M.P.H., Kaiser Permanente Washington Health Research Institute, Seattle, and coauthors

Related Material

The following related elements from the JAMA Network are also available on the For The Media website:

— A video abstract is available to view on this page and to embed on your website by copying and pasting the HTML code below. To download the video, email mediarelations@jamanetwork.org for information.

— The JAMA editorial, “Preventing Macrovascular Events With Bariatric Surgery,” by Sayeed lkramuddin, M.D., M.H.A., University of Minnesota, Minneapolis, and coauthors.

— The JAMA Surgery editorial: “Standardized Uniform Reporting and Indications for Bariatric and Metabolic Surgery,” by Paulina Salminen, M.D., Turku University Hospital, Turku, Finland.

— The JAMA study, “Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes,” by Wendy C. King, Ph.D., University of Pittsburgh, and coauthors.

The JAMA editorial, “Setting Appropriate Expectations After Bariatric Surgery,” by Amir A. Ghaferi, M.D., M.S., and Oliver A. Varban, M.D., University of Michigan, Ann Arbor.

Previously published by JAMA: Bariatric Surgery for Type 2 Diabetes

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.14619)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Video embed code:

<div style="display: block; position: relative; max-width: 300px;"><div style="padding-top: 50%;"><iframe src="//players.brightcove.net/864352215001/default_default/index.html?videoId=5842889876001" allowfullscreen webkitallowfullscreen mozallowfullscreen style="width: 100%; height: 100%; position: absolute; top: 0px; bottom: 0px; right: 0px; left: 0px;"></iframe></div></div>

The photos below accompany the article and are available for use. Right click to save the image.

Caption: Engraved pills memorializing those who die each year due to prescription opioid misuse.

Caption: Details of the pill engraving.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 9, 2018

Media advisory: To contact corresponding author Alison G. Cahill, M.D., M.S.C.I., email Diane Duke Williams at Williamsdia@wustl.edu. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.13986

Bottom Line: The best time to push during the second stage of labor (when the cervix is completely dilated through delivery) is unknown and it’s unclear whether the timing affects rates of natural delivery or possible complications. The two most common approaches are either immediate pushing (pushing with uterine contractions once complete cervical dilation occurs) or delayed pushing to allow for spontaneous descent of the fetus. In this randomized clinical trial, immediate pushing compared with delayed pushing didn’t result in a significant difference in the rates of spontaneous vaginal delivery (without the use of forceps, vacuum or cesarean delivery) or overall adverse outcomes among newborns. Rates of hemorrhage and infection were higher among women in the delayed pushing group. The clinical trial included about 2,400 women who received pain medication for labor and delivery and who had not previously given birth. This study may not have been able to detect clinically important differences in some other outcomes.

Authors: Alison G. Cahill, M.D., M.S.C.I., Washington University in St. Louis, and coauthors

Related Material

The following related elements from the JAMA Network are also available on the For The Media website:

— The editorial, “Immediate vs Delayed Pushing During the Second Stage of Labor,” by Jeffrey D. Sperling, M.D., M.S., and Dana R. Gossett, M.D., M.S.C.I., of the University of California, San Francisco.

— A video abstract is available to view on this page and to embed on your website by copying and pasting the HTML code below. The transcript is available here. To download the video, email mediarelations@jamanetwork.org for information.

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.13986)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Video embed code:

<div style="display: block; position: relative; max-width: 300px;"><div style="padding-top: 50%;"><iframe src="//players.brightcove.net/864352215001/default_default/index.html?videoId=5831219351001" allowfullscreen webkitallowfullscreen mozallowfullscreen style="width: 100%; height: 100%; position: absolute; top: 0px; bottom: 0px; right: 0px; left: 0px;"></iframe></div></div>

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 9, 2018

Media advisory: To contact corresponding author C. Mary Healy, M.D., email Jeannette Jimenez at Jeannette.Jimenez@bcm.edu. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14298

Bottom Line: Risk of whooping cough (pertussis) is highest in infants too young to have completed their primary immunization series (6 months old or younger) and they are at highest risk of developing life-threatening complications. Immunizing pregnant women with the tetanus, diphtheria and acellular pertussis (Tdap) vaccine can create enough maternal antibodies to protect infants, but the best time to immunize mothers to maximize concentrations of neonatal pertussis toxin antibodies is unknown. This observational study included 626 pregnancies and compared pertussis antibody concentrations in umbilical cord blood among newborns whose mothers received Tdap immunization in the third trimester, as is recommended by the U.S. Centers for Disease Control and Prevention, with those whose mothers didn’t receive the Tdap vaccine during pregnancy. Maternal immunization with the Tdap vaccine during the third trimester of pregnancy was associated with higher concentrations of pertussis antibodies in infants at birth, with immunization early in the third trimester associated with the highest concentrations of antibodies. Definitive antibody concentration levels for immunity from whooping cough for infants are unknown. The study design doesn’t allow for cause-and-effect interpretations of the findings.

Authors: C. Mary Healy, M.D., Baylor College of Medicine, Houston, and coauthors

Related Material

Previously published by JAMA: Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.14298)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 2, 2018

Media advisory: To contact corresponding author George Howard, Dr.P.H., email Holly Gainer at hgainer@uab.edu. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.13467

Bottom Line: High blood pressure is widespread among black adults in the United States and it is a major contributor to disparities in life expectancy, although reasons for this increased hypertension risk are unknown. Researchers examined 12 factors and their association with the development of hypertension among 6,900 black and white adults who didn’t have hypertension when they entered the study in 2003-2007 and who were followed-up nine years later. The biggest factor associated with increased risk of hypertension among black adults was high consumption of a Southern diet, which was defined as eating lots of fried foods, organ meats, processed meats, eggs and egg dishes, added fats, high-fat dairy foods, sugar-sweetened beverages and bread.

Authors: George Howard, Dr.P.H., University of Alabama at Birmingham, and coauthors

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.13467)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Related Material

Previously published by the JAMA Network:

Racial Differences in Associations of Blood Pressure Components in Young Adulthood With Incident Cardiovascular Disease by Middle Age

Racial Differences in the Impact of Elevated Systolic Blood Pressure on Stroke Risk

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, OCTOBER 2, 2018

Media advisory: To contact corresponding author Martin Feller, M.D., M.Sc., email martin.feller@insel.ch. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.13770

Bottom Line: An early form of underactive thyroid (when the body doesn’t produce enough thyroid hormones) called subclinical hypothyroidism is a common condition but the benefit of thyroid hormone therapy on quality of life and symptoms is uncertain. This study, which analyzed the combined results of 21 randomized clinical trials with 2,200 participants with subclinical hypothyroidism, reports that thyroid hormone therapy wasn’t associated with improved quality of life or thyroid-related symptoms. The authors suggest the results don’t support routine use of thyroid hormone therapy in adults with subclinical hypothyroidism.

Authors: Martin Feller, M.D., M.Sc., University of Bern, Switzerland, and coauthors

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.13770)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Related Material

Previously published by JAMA:

Thyroid-Stimulating Hormone in the Evaluation of Subclinical Hypothyroidism

Subclinical Thyroid Dysfunction and Fracture Risk

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, OCTOBER 1, 2018

Media advisory: To contact corresponding author Douglas J. Wiebe, Ph.D., email Greg Richter at greg.richter@pennmedicine.upenn.edu. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14165

Bottom Line: The kickoff return in football has been associated with a substantial number of concussions because players run toward each other and there is potential for significant hits. In 2015, kickoffs accounted for 6 percent of all plays but 21 percent of concussions in the Ivy League, a Division 1 conference of eight private universities. Ivy League football coaches recommended a rule change and, in 2016, the kickoff and touchback line were moved to reduce the likelihood of a player advancing the ball on a kickoff. A new research letter reports that during 68,479 plays from 2013 through 2017, there were 159 concussions (126 before the rule change and 33 after). The average annual concussion rate per 1,000 kickoff plays was 10.93 before the rule change (2013-2015) and 2.04 after (2016-2017). Although these results may not be generalizable beyond the Ivy League, they could be helpful to the National Collegiate Athletic Association (NCAA) as it considers adjusting kickoff rules in all collegiate football conferences.

Authors: Douglas J. Wiebe, Ph.D., University of Pennsylvania, Philadelphia, and coauthors

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.14165)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 24, 2018

Media advisory:  For more information, email JAMA Network Media Relations at mediarelations@jamanetwork.org. The articles are available on the For The Media website.

Bottom Line: A collection of JAMA articles (an editorial and three Viewpoints) focuses on race, medicine and medical research. Excerpts of the articles are below along with links that will be live when the embargo lifts.

Editorial: “Race, Ancestry, and Medical Research,” by JAMA Executive Editor Phil B. Fontanarosa, M.D., M.B.A., and JAMA Editor in Chief Howard Bauchner, M.D.

Article Excerpt: 

Want to embed a link to this article in your story? Link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.14438

Viewpoint: “Race, Ancestry, and Reporting in Medical Journals,” by Richard S. Cooper, M.D., Loyola University Medical School, Maywood, Illinois, and coauthors

Article Excerpt:

Want to embed a link to this article in your story? Link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.10960

Viewpoint: “Historical Aspects of Race and Medicine – The Case of J. Marion Sims,” by Keith Wailoo, Ph.D., Princeton University, Princeton, New Jersey

Article Excerpt:

Want to embed a link to this article in your story? Link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.11944

Viewpoint: “Examining How Race, Ethnicity, and Ancestry Data Are Used in Biomedical Research,” by Vence L. Bonham, J.D., National Institutes of Health, Bethesda, Maryland, and coauthors

Article Excerpt:

Want to embed a link to this article in your story? Link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.13609

To Learn More: All the articles are available on the For The Media website.

Editor’s Note: Please see the articles for additional information, including other authors, author contributions and affiliations, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 25, 2018

Media advisory: To contact corresponding author Paulina Salminen, M.D., Ph.D., email paulina.salminen@tyks.fi. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.13201

Bottom Line: About 60 percent of patients with uncomplicated acute appendicitis who were initially treated with antibiotics did not undergo appendectomy in five years in a follow-up to a randomized clinical trial. The clinical trial included 273 patients who had an appendectomy and 257 patients initially treated with antibiotics for uncomplicated acute appendicitis. In all, 100 of 257 patients initially treated with antibiotics underwent appendectomy during the five-year course of this study, including 15 patients operated on during the initial hospitalization. The findings suggest antibiotics may be a feasible alternative to surgery for patients with uncomplicated acute appendicitis.

Authors: Paulina Salminen, M.D., Ph.D., Turku University Hospital, Turku, Finland, and coauthors

Related Material

The following related elements from the JAMA Network are also available on the For The Media website:

— The editorial, “Antibiotic Treatment for Uncomplicated Appendicitis Really Works,” by Edward H. Livingston, M.D., Deputy Editor, JAMA

— A video abstract is available to embed on your website by copying and pasting the HTML code below. The transcript is available here. To download the video, email mediarelations@jamanetwork.org for information.

Previously published by the JAMA Network:

Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis – The APPAC Randomized Clinical Trial

Patient Preferences for Surgery or Antibiotics for the Treatment of Acute Appendicitis

Comparison of Antibiotic Therapy and Appendectomy for Acute Uncomplicated Appendicitis in Children – A Meta-analysis

Effectiveness of Patient Choice in Nonoperative vs Surgical Management of Pediatric Uncomplicated Acute Appendicitis

Antibiotics vs Surgery for Acute Appendicitis: Toward a Patient-Centered Treatment Approach

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.13201)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Video embed code:

<div style="display: block; position: relative; max-width: 300px;"><div style="padding-top: 50%;"><iframe src="//players.brightcove.net/864352215001/default_default/index.html?videoId=5829368006001" allowfullscreen webkitallowfullscreen mozallowfullscreen style="width: 100%; height: 100%; position: absolute; top: 0px; bottom: 0px; right: 0px; left: 0px;"></iframe></div></div>

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 25, 2018

Media advisory: To contact corresponding author Thomas H. McCoy Jr., M.D., email Noah Brown at nbrown9@partners.org. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.9222

Bottom Line: The ongoing transition to electronic health records may increase data breaches involving patient records. An analysis of reported breaches of health data from 2010 through 2017 found that except for 2015, the number of breach reports increased each year. During this time there were 2,149 breaches comprising a total of 176.4 million records. The most common entity breached was a health care provider, with 1,503 breaches (70 percent) compromising a total of 37.1million records. Health plans accounted for the largest share of breached records (110.4 million). There was an increasing number of breaches associated with health care providers over time. The greatest numbers of records breached were accessed via network-connected information. A limitation of the study is that the results describe trends but do not allow for inferences about the causes of those trends.

Authors: Thomas H. McCoy Jr., M.D., and Roy H. Perlis, M.D., M.Sc., Massachusetts General Hospital, Boston, and Associate Editor, JAMA Network Open (Dr. Perlis)

Related Material

Previously published by JAMA:

Data Breaches of Protected Health Information in the United States

Keeping Personal Health Information Safe

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.9222)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

FOR IMMEDIATE RELEASE: SEPTEMBER 19, 2018

Media advisory: To contact JAMA Network Media Relations email mediarelations@jamanetwork.org.

CHICAGO – JAMA, JAMA Internal Medicine and JAMA Pediatrics have retracted six articles that included Brian Wansink, Ph.D., of Cornell University, Ithaca, New York, as author. Below is the notice of retraction published online today by JAMA, which references the retracted articles (see references 4-9). Similar notices were published online today in JAMA Internal Medicine and JAMA Pediatrics.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 18, 2018

Media advisory: To contact corresponding author Liselotte N. Dyrbye, M.D., M.H.P.E., email Robert Nellis at newsbureau@mayo.edu. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.12615

Bottom Line: Burnout is common among physicians. But do rates of burnout symptoms and career-choice regret vary among physicians in training by clinical specialty? In a study of nearly 3,600 second-year residents who were followed-up with questionnaires since medical school, 45 percent reported burnout symptoms and 14 percent reported regret over their career choice. The frequency of burnout symptoms and career-choice regret varied widely by specialty. Residents who trained in urology, neurology, emergency medicine or general surgery were more likely to report burnout symptoms compared with residents training in internal medicine, while residents who trained in pathology and anesthesiology were more likely to report career regret. Limitations of this observational study include that study participants may not be representative of all U.S. resident physicians. Regardless of specialty, high levels of anxiety and low levels of empathy reported during medical school were associated with burnout symptoms during residency.

Authors: Liselotte N. Dyrbye, M.D., M.H.P.E., Mayo Clinic, Rochester, Minnesota and coauthors

Related Material

The following related elements from The JAMA Network are also available on the For The Media website:

— The JAMA study, “Prevalence of Burnout Among Physicians.”

— The JAMA editorial, “Physician Burnout—A Serious Symptom, But of What?”

Previously published:

— From JAMA Surgery, “Multiple-Institution Comparison of Resident and Faculty Perceptions of Burnout and Depression During Surgical Training.”

— From JAMA Internal Medicine, “Workplace Factors Associated With Burnout of Family Physicians.”

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.12615)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 18, 2018

Media advisory: To contact the U.S. Preventive Services Task Force, email the media coordinator at Newsroom@USPSTF.net or call 202-572-2044. The full report is available on the For The Media website.

Want to embed a link to this report in your story? Link will be live at the embargo time and all links to all USPSTF articles remain free indefinitely: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.13022

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive behavioral interventions that focus on dietary changes and increased physical activity and that provide a variety of components to support weight loss and to maintain it.

Background: The USPSTF routinely makes recommendations about the effectiveness of preventive care services. This latest statement is an update of its 2012 recommendation on screening for obesity in adults. More than 35 percent of men and 40 percent of women in the United States are obese. Obesity is associated with health problems such as increased risk for coronary heart disease, type 2 diabetes. various types of cancer and disability. Obesity is also associated with an increased risk for death, particularly among adults younger than 65 years.

The USPSTF Concludes:

Related Material

The following related elements from The JAMA Network are also available on the For The Media website:

Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults – U.S. Preventive Services Task Force Recommendation Statement

Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults – Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

JAMA editorial: Weight Management in Adults With Obesity

JAMA Internal Medicine editorial: Treating Obesity – Moving From Recommendation to Implementation

JAMA Patient Page: Behavioral Interventions for Weight Loss

To Learn More: The full report is available on the For The Media website.

(doi:10.1001/jama.2018.13022)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

A video abstract is available for the JAMA study, “Effect of Piperacillin-Tazobactam vs Meropenem in E coli or Klebsiella pneumoniae Infection.” It is available for download or to embed on your website. Download the video as a high-quality MP4 file by clicking on this link and then right-clicking and selecting “save video as.” In addition, you may copy and paste the HTML code below to embed the video on your website.

Video embed code:

<div style="display: block; position: relative; max-width: 300px;"><div style="padding-top: 50%;"><iframe src="//players.brightcove.net/864352215001/default_default/index.html?videoId=5826583495001" allowfullscreen webkitallowfullscreen mozallowfullscreen style="width: 100%; height: 100%; position: absolute; top: 0px; bottom: 0px; right: 0px; left: 0px;"></iframe></div></div>

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 11, 2018

Media advisory: To contact corresponding author Boyd E. Metzger, M.D., email Marla Paul at marla-paul@northwestern.edu. The full study is available on the For The Media website.

Want to embed a link to this study in your story? Link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.11628

Bottom Line: Newer criteria mean more women are diagnosed with gestational diabetes than before. This observational study assessed whether untreated gestational diabetes defined after the fact based on newer criteria was associated with long-term risk of glucose metabolism disorders among 4,700 mothers and overweight or obesity in their children 10 to 14 years after pregnancy. Researchers report that untreated gestational diabetes was associated with development of glucose metabolism disorders (a composite of type 2 diabetes or prediabetes) in mothers but was not significantly associated with childhood overweight/obesity in combination. However, additional measures of fatness in children may be relevant in interpreting the study findings.

Authors: Boyd E. Metzger, M.D., Northwestern University Feinberg School of Medicine, Chicago, and coauthors

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jama.2018.11628)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.